tiprankstipranks
Ocean Biomedical Faces Nasdaq Delisting Threat
PremiumCompany AnnouncementsOcean Biomedical Faces Nasdaq Delisting Threat
3M ago
Ocean Biomedical receives noncompliance letter from Nasdaq
Premium
The Fly
Ocean Biomedical receives noncompliance letter from Nasdaq
4M ago
Ocean Biomedical, Molecure sign licensing agreement for YKL-40 inhibitors
Premium
The Fly
Ocean Biomedical, Molecure sign licensing agreement for YKL-40 inhibitors
4M ago
Ocean Biomedical congratulates joint venture partner Virion Therapeutics
PremiumThe FlyOcean Biomedical congratulates joint venture partner Virion Therapeutics
9M ago
Ocean Biomedical Faces Nasdaq Non-Compliance Notice and Delays
Premium
Company Announcements
Ocean Biomedical Faces Nasdaq Non-Compliance Notice and Delays
9M ago
Ocean Biomedical receives notice of non-compliance from Nasdaq
Premium
The Fly
Ocean Biomedical receives notice of non-compliance from Nasdaq
9M ago
Ocean Biomedical Inc options imply 21.0% move in share price post-earnings
PremiumThe FlyOcean Biomedical Inc options imply 21.0% move in share price post-earnings
11M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
11M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100